journal article·2023-01Open access

Genetic and Pharmacological Inhibition of Astrocytic Mysm1 Alleviates Depressive‐Like Disorders by Promoting ATP Production

Heyang Zhang, Shuirong Liu, Qiaozhen Qin, Zhenhua Xu, Yannv Qu, Yadi Wang, Jianing Wang, Zhangzhen Du, Shanshan Yuan, Shunming Hong, Zhilin Chang, Wenyan He, Xinlong Yan, Yiran Lang, Rongyu Tang, Yan Wang, Lingling Zhu, Xiaoxia Jiang

Advanced Science· Volume 10· Issue 1

Abstract

Abstract Major depressive disorder (MDD) is a leading cause of disability worldwide. A comprehensive understanding of the molecular mechanisms of this disorder is critical for the therapy of MDD. In this study, it is observed that deubiquitinase Mysm1 is induced in the brain tissues from patients with major depression and from mice with depressive behaviors. The genetic silencing of astrocytic Mysm1 induced an antidepressant‐like effect and alleviated the osteoporosis of depressive mice. Furthermore, it is found that Mysm1 knockdown led to increased ATP production and the activation of p53 and AMP‐activated protein kinase (AMPK). Pifithrin α (PFT α) and Compound C, antagonists of p53 and AMPK, respectively, repressed ATP production and reversed the antidepressant effect of Mysm1 knockdown. Moreover, the pharmacological inhibition of astrocytic Mysm1 by aspirin relieved depressive‐like behaviors in mice. The study reveals, for the first time, the important function of Mysm1 in the brain, highlighting astrocytic Mysm1 as a potential risk factor for depression and as a valuable target for drug discovery to treat depression.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Diet and metabolism studies · Tryptophan and brain disorders · Mitochondrial Function and Pathology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Beijing Institute of Basic Medical Sciences 27 Taiping Road, Haidian District Beijing 100850 China

Faculty of Environmental and Life Sciences Beijing University of Technology Beijing 100124 China

Department of Geriatrics Peking University Shenzhen Hospital Shenzhen Guangzhou 518036 China

China National Clinical Research Center for Neurological Diseases Jing‐Jin Center for Neuroinflammation Beijing Tiantan Hospital Capital Medical University Beijing 100050 China

Beijing Innovation Center for Intelligent Robots and Systems Beijing Institute of Technology Beijing 100081 China

Anhui Medical University Hefei Anhui 230032 China

Co‐innovation Center of Neuroregeneration Nantong University Nantong 226019 China

Funding

Natural Science Foundation of Beijing Municipality · National Natural Science Foundation of China

References (62)

Show source-provided references
1. 10.1016/S0140-6736(18)31948-210.1016/S0140-6736(18)31948-2 ↗
2. Aalbers S. · Cochrane Database Syst Rev · 2017 · 11
3. 10.1186/s12974-020-01871-910.1186/s12974-020-01871-9 ↗
4. 10.1111/j.1749-6632.2009.05218.x10.1111/j.1749-6632.2009.05218.x ↗
5. 10.1242/dmm.03091610.1242/dmm.030916 ↗
6. 10.2147/DDDT.S22143710.2147/DDDT.S221437 ↗
7. 10.1038/s41419-019-1813-910.1038/s41419-019-1813-9 ↗
8. 10.26599/JNR.2022.904000410.26599/JNR.2022.9040004 ↗
9. 10.1016/j.neuron.2018.08.03110.1016/j.neuron.2018.08.031 ↗
10. 10.1038/mp.2017.22910.1038/mp.2017.229 ↗
11. 10.1016/j.immuni.2015.09.01010.1016/j.immuni.2015.09.010 ↗
12. 10.1016/j.celrep.2020.10829710.1016/j.celrep.2020.108297 ↗
13. 10.1038/s41467-018-07016-010.1038/s41467-018-07016-0 ↗
14. 10.1007/s13277-015-4138-z10.1007/s13277-015-4138-z ↗
15. 10.1016/j.jaci.2016.10.05310.1016/j.jaci.2016.10.053 ↗
16. 10.1002/advs.20200195010.1002/advs.202001950 ↗
17. 10.1016/j.gene.2020.14493810.1016/j.gene.2020.144938 ↗
18. 10.1038/nature2550910.1038/nature25509 ↗
19. 10.1073/pnas.060423410310.1073/pnas.0604234103 ↗
20. 10.1038/sj.jcbfm.960034310.1038/sj.jcbfm.9600343 ↗
21. 10.1002/glia.2059010.1002/glia.20590 ↗
22. 10.1182/blood-2014-05-57411110.1182/blood-2014-05-574111 ↗
23. 10.1038/nrm331110.1038/nrm3311 ↗
24. 10.1097/MOL.0b013e328328d0a410.1097/MOL.0b013e328328d0a4 ↗
25. 10.3389/fphys.2018.0125810.3389/fphys.2018.01258 ↗
26. Goru S. K. · Pharmacol Rep · 2017
27. 10.1038/cdd.2014.23110.1038/cdd.2014.231 ↗
28. 10.18632/oncotarget.1861710.18632/oncotarget.18617 ↗
29. 10.1016/j.jaci.2015.06.00810.1016/j.jaci.2015.06.008 ↗
30. 10.1111/jcmm.1655410.1111/jcmm.16554 ↗
31. 10.1182/blood-2011-05-35266610.1182/blood-2011-05-352666 ↗
32. 10.1038/nature2575210.1038/nature25752 ↗
33. 10.1038/mp.2016.11810.1038/mp.2016.118 ↗
34. 10.1038/nature0982010.1038/nature09820 ↗
35. Chunpeng X. · Front Behav Neurosci · 2018 · 12 · 238
36. 10.1371/journal.pone.001945010.1371/journal.pone.0019450 ↗
37. 10.1007/s00213-013-3235-110.1007/s00213-013-3235-1 ↗
38. 10.3389/fnbeh.2013.0001710.3389/fnbeh.2013.00017 ↗
39. 10.1016/j.tips.2016.11.00110.1016/j.tips.2016.11.001 ↗
40. 10.1038/s41386-019-0396-610.1038/s41386-019-0396-6 ↗
41. 10.1007/s11033-018-4405-310.1007/s11033-018-4405-3 ↗
42. 10.1016/j.neubiorev.2018.08.00710.1016/j.neubiorev.2018.08.007 ↗
43. 10.1038/nm.316210.1038/nm.3162 ↗
44. 10.15252/embr.20194785710.15252/embr.201947857 ↗
45. 10.1016/j.neuroscience.2020.03.02510.1016/j.neuroscience.2020.03.025 ↗
46. 10.1161/CIRCRESAHA.119.31630610.1161/CIRCRESAHA.119.316306 ↗
47. 10.1038/s41573-020-0072-x10.1038/s41573-020-0072-x ↗
48. 10.1002/glia.2380810.1002/glia.23808 ↗
49. 10.1016/j.molcel.2016.01.01010.1016/j.molcel.2016.01.010 ↗
50. 10.1016/j.immuni.2011.11.01010.1016/j.immuni.2011.11.010 ↗
51. 10.1182/blood-2013-03-48964110.1182/blood-2013-03-489641 ↗
52. 10.3390/ijms1903068710.3390/ijms19030687 ↗
53. 10.1002/jcp.2611810.1002/jcp.26118 ↗
54. 10.1038/s41419-021-04208-310.1038/s41419-021-04208-3 ↗
55. 10.1186/1741-7015-11-7410.1186/1741-7015-11-74 ↗
56. 10.1158/0008-5472.CAN-16-240010.1158/0008-5472.CAN-16-2400 ↗
57. 10.1016/j.jad.2019.09.01310.1016/j.jad.2019.09.013 ↗
58. 10.1002/emmm.20120225810.1002/emmm.201202258 ↗
59. 10.1038/nmeth.132210.1038/nmeth.1322 ↗
60. Fiehn O. · Nat. Biotechnol. · 2001 · 19 · 173
61. 10.1152/ajpcell.00607.200410.1152/ajpcell.00607.2004 ↗
62. Müller R. · Stud. Health Technol. Inform. · 1997 · 40 · 61